Date of Award
Campus Access Dissertation
Doctor of Philosophy (PhD)
Jan E. Mutchler
Edward A. Miller
Advance care directives and medical orders to limit life-sustaining treatments guide families and clinicians about the appropriate types of care for patients facing a life-threatening illness. Some studies have examined how clinicians might influence patient decisions and others have studied how proxy decisions differed from patients’ in hypothetical scenarios. No known study has examined how clinician training and proxy decision-makers influence decisions about life-sustaining treatments in a severely ill patient population.
The Physician (or Medical) Orders for Life-Sustaining Treatment (POLST or MOLST) conveys a patient’s or proxy decision-maker’s consent to administer or withhold treatments that could extend life. This study collected and analyzed data from 593 Massachusetts MOLSTs and their corresponding patient electronic health records at three hospitals. Proxy decision-makers signed 43% of the forms. Physicians signed 52% and nurse practitioners or physician assistants signed the remainder (48%); 50% of the clinicians were palliative care specialists.
Multivariate logistic regression analyses estimated the likelihood for All Treatment vs. Limit Treatment. A highly significant model (p=80 years old were 79% (OR=0.22; p
High illness severity, proxy decision-makers, and increasing age independently decreased the likelihood for specifying All Treatment on a MOLST Form. Hospitals may want to use these attributes to prioritize patients who should complete a MOLST (or POLST) due to their increased likelihood for preferring to limit life-sustaining treatments. Patients nearing the end-of-life often receive medical care in multiple settings; MOLSTs or POLSTs can prevent unwanted treatments when patients are no longer able to communicate.
Chen, Elizabeth C., "Letting Go: The Influence of Clinicians and Proxy Decision-Makers on Preferences for Life-Sustaining Treatments" (2016). Graduate Doctoral Dissertations. 252.